Roche posted a big Q1 sales gain. So why is the company expecting a slowdown later this year?news2022-04-25T10:19:56+00:00April 25th, 2022|Fierce Pharma|
Gilead touts analysis showing COVID antiviral Veklury performs best when given early in illnessnews2022-04-24T17:49:14+00:00April 24th, 2022|Fierce Pharma|
IBSA enlists PGA golfer James Hahn as spokesman for Licart pain patchnews2022-04-22T17:56:45+00:00April 22nd, 2022|Fierce Pharma|
After Brexafemme approval, Scynexis touts data that could broaden the antifungal’s reachnews2022-04-22T15:12:07+00:00April 22nd, 2022|Fierce Pharma|
With 200M unused doses, AstraZeneca’s COVID vaccine partner Serum Institute halts productionnews2022-04-22T14:55:34+00:00April 22nd, 2022|Fierce Pharma|
As US launch falters, Biogen ditches Aduhelm application in Europenews2022-04-22T14:50:03+00:00April 22nd, 2022|Fierce Pharma|
After manufacturing hiccup, Revance set for September FDA decision on Botox rivalnews2022-04-22T14:05:36+00:00April 22nd, 2022|Fierce Pharma|
WHO gives a thumbs up to Pfizer’s Paxlovid while scolding the company for its ‘lack of price transparency’news2022-04-22T13:43:07+00:00April 22nd, 2022|Fierce Pharma|
Regeneron CEO’s pay drops 95%—but that shouldn’t come as a shocknews2022-04-22T12:27:20+00:00April 22nd, 2022|Fierce Pharma|
Fierce Pharma Asia—Merck’s Romanelli returns; Sanofi’s ‘factory of the future’; Fujifilm’s $450M contractnews2022-04-22T11:54:42+00:00April 22nd, 2022|Fierce Pharma|
